By Jelena Martinovic.
Radient Technologies Inc. RDDTF said Tuesday it has entered a supply agreement with Medical Cannabis by Shoppers, Shoppers Drug Mart’s online medical cannabis platform.
Radient Technologies will develop a new variety of cannabinoid formulations under a brand available only to Medical Cannabis by Shoppers’ patients, according to the three-year agreement.
The company said it will employ a proprietary extraction method and downstream processing platform, recovering up to 99% of active compounds from the cannabis plant.
This extraction technology has a low risk of cannabinoid degradation during processing, delivering products with first-class consistency and long-term stability, according to Radient.
Benzinga's Cannabis Capital Conference returns to Miami Feb. 24-25 with North America's largest B2B cannabis gathering, bringing together capital, cannabis executives, thought leaders and more!
Radient is proud to partner with Shoppers, a leading Canadian pharmacy retailer, Denis Taschuk, president and CEO of Radient, said in a statement.
"This is an incredible milestone for Radient. We are very proud of what we have achieved as a company over the last two years, and this partnership is a monumental leap forward."
The agreement is subject to renewal for an additional two years or early termination.
Public domain photo via Wikimedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.